X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4132) 4132
Publication (213) 213
Book Review (22) 22
Dissertation (20) 20
Book Chapter (14) 14
Paper (6) 6
Web Resource (4) 4
Magazine Article (3) 3
Conference Proceeding (2) 2
Book / eBook (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
carvedilol (3961) 3961
humans (2168) 2168
male (1562) 1562
cardiac & cardiovascular systems (1483) 1483
female (1244) 1244
adrenergic beta-antagonists - therapeutic use (1105) 1105
heart failure (1090) 1090
index medicus (1079) 1079
middle aged (1008) 1008
heart failure - drug therapy (879) 879
pharmacology & pharmacy (835) 835
aged (828) 828
mortality (794) 794
propanolamines - therapeutic use (762) 762
carbazoles - therapeutic use (744) 744
metoprolol (725) 725
animals (575) 575
treatment outcome (554) 554
adult (516) 516
propanolamines - pharmacology (483) 483
carbazoles - pharmacology (474) 474
heart failure - physiopathology (447) 447
adrenergic beta-antagonists - pharmacology (429) 429
survival (424) 424
beta-blockers (388) 388
hypertension (385) 385
rats (348) 348
chronic heart-failure (335) 335
trial (327) 327
therapy (320) 320
heart rate - drug effects (317) 317
morbidity (305) 305
adrenergic beta-antagonists - administration & dosage (298) 298
propanolamines - administration & dosage (298) 298
dilated cardiomyopathy (295) 295
double-blind (295) 295
blood pressure - drug effects (292) 292
carbazoles - administration & dosage (292) 292
medicine, general & internal (283) 283
heart failure - mortality (280) 280
heart-failure (260) 260
beta-blocker (250) 250
dose-response relationship, drug (248) 248
follow-up studies (243) 243
prognosis (239) 239
peripheral vascular disease (237) 237
prospective studies (236) 236
chronic disease (234) 234
double-blind method (234) 234
drug therapy (223) 223
oxidative stress (221) 221
left-ventricular dysfunction (214) 214
aged, 80 and over (211) 211
cardiac patients (211) 211
adrenergic beta-antagonists - adverse effects (210) 210
cardiovascular (210) 210
hypertension - drug therapy (210) 210
angiotensin-converting enzyme inhibitors - therapeutic use (206) 206
dysfunction (202) 202
analysis (199) 199
time factors (199) 199
metoprolol - therapeutic use (197) 197
cardiology (195) 195
management (193) 193
cardiomyopathy (191) 191
care and treatment (186) 186
myocardial-infarction (186) 186
echocardiography (183) 183
propranolol (180) 180
idiopathic dilated cardiomyopathy (179) 179
beta blockers (175) 175
disease (174) 174
nebivolol (173) 173
retrospective studies (173) 173
propanolamines - adverse effects (168) 168
hemodynamics - drug effects (167) 167
medicine & public health (167) 167
carbazoles - adverse effects (165) 165
drug therapy, combination (165) 165
stroke volume - drug effects (162) 162
ventricular function, left - drug effects (161) 161
acute myocardial-infarction (159) 159
heart (159) 159
risk factors (158) 158
congestive-heart-failure (157) 157
heart rate (156) 156
left-ventricular function (155) 155
antihypertensive agents - therapeutic use (153) 153
randomized controlled trials as topic (153) 153
bisoprolol (151) 151
ventricular dysfunction, left - drug therapy (151) 151
outcomes (146) 146
randomized-trial (145) 145
propanolamines - pharmacokinetics (143) 143
carbazoles - pharmacokinetics (140) 140
blockade (139) 139
pharmacokinetics (139) 139
exercise (138) 138
abridged index medicus (134) 134
chronic heart failure (133) 133
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3883) 3883
Russian (65) 65
German (60) 60
Spanish (31) 31
Japanese (25) 25
Portuguese (21) 21
French (19) 19
Korean (16) 16
Chinese (12) 12
Italian (9) 9
Hungarian (8) 8
Turkish (8) 8
Czech (7) 7
Polish (5) 5
Croatian (4) 4
Slovak (2) 2
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Molecular Liquids, ISSN 0167-7322, 11/2019, Volume 294, p. 111622
In recent years, various polymorphic forms have been identified, including solvates of carvedilol. In this study, the solubility values of a thermodynamically... 
Correlation | Nanoparticle | Carvedilol | Solubility
Journal Article
Journal of Pharmaceutical Innovation, ISSN 1872-5120, 2018
Journal Article
09/2013
Purpose: To develop and optimize carvedilol transdermal delivery system. Methods: Solvent casting method was used to prepare patches using polymethyl... 
Drug release | Central composite design | Carvedilol | Transdermal patch
Web Resource
12/2012
Purpose: To evaluate the effect of two molecular weight grades of hydroxypropyl methylcellulose on the release characteristics of carvedilol phosphate matrix... 
Release kinetics | Hydroxypropyl methylcellulose | Carvedilol phosphate | Matrix tablet
Web Resource
GASTROENTEROLOGY, ISSN 0016-5085, 10/2014, Volume 147, Issue 4, pp. 942 - 942
Journal Article
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 09/2015, Volume 42, Issue 9, pp. 972 - 978
Summary Oxidative stress plays an important role in the pathogenesis of diabetic nephropathy. The β‐blocker carvedilol has been proven to have an anti‐oxidant... 
diabetic nephropathy | oxidative stress | carvedilol | Oxidative stress | Diabetic nephropathy | Carvedilol
Journal Article
LANCET, ISSN 0140-6736, 09/2010, Volume 376, Issue 9744, pp. 875 - 885
Background Chronic heart failure is associated with high mortality and morbidity. Raised resting heart rate is a risk factor for adverse outcomes. We aimed to... 
RATE REDUCTION | SURVIVAL | CARVEDILOL | MEDICINE, GENERAL & INTERNAL | MORBIDITY | CARDIAC-RHYTHM | SYSTOLIC DYSFUNCTION BEAUTIFUL | GUIDELINES | DOUBLE-BLIND | METOPROLOL | CORONARY-ARTERY-DISEASE
Journal Article
Acta Medica Iranica, ISSN 0044-6025, 03/2019, Volume 57, Issue 3, pp. 173 - 179
Breast cancer is the most common cancer among the female population, and its prevalence is increasing worldwide. Trastuzumab (Herceptin) therapy improves... 
Breast cancer | Cardiomyopathy | Carvedilol | Trastuzumab
Journal Article
Trials, ISSN 1745-6215, 02/2018, Volume 19, Issue 1, pp. 103 - 9
Journal Article
04/2011
Objective: Dilated cardiomyopathy is the end result of chronic iron overload in patients with beta thalassemia major. The objective of the present study was to... 
Beta thalassemia major | Dilated cardiomyopathy | Carvedilol | Heart filure
Web Resource
Toxicology and applied pharmacology, ISSN 0041-008X, 09/2019, p. 114750
Hepatic ischemia/reperfusion injury (H-IRI) is associated with irreversible liver damage. The current study aimed to investigate the protective effect of... 
Journal Article
Powder Technology, ISSN 0032-5910, 09/2006, Volume 167, Issue 1, pp. 20 - 25
The objective of the present study was to develop a stable amorphous form of model drug carvedilol (CAR). The amorphous material produced by melt quench... 
Amorphous | Enthalpy relaxation | Solid dispersion | Stability | Carvedilol
Journal Article
Powder Technology, ISSN 0032-5910, 09/2019, Volume 354, pp. 348 - 357
The aim of this study was to produce redispersible spray-dried carvedilol-loaded nanocapsules and to evaluate their mucoadhesiveness as well as drug... 
Sublingual permeability | Powders | Spray-drying | Mucoadhesion | Carvedilol | Nanocapsules
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2018, Volume 71, Issue 7, pp. 727 - 735
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.